Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer.
about
Maintenance of open chromatin and selective genomic occupancy at the cell cycle-regulated histone H4 promoter during differentiation of HL-60 promyelocytic leukemia cellsThe retinoblastoma family: twins or distant cousins?Accurate diagnosis of thyroid follicular lesions from nuclear morphology using supervised learning.Immobility, inheritance and plasticity of shape of the yeast nucleus.Telomerase activation by histone deacetylase inhibitor in normal cells.Regulation of the human catalytic subunit of telomerase (hTERT).Aberrant silencing of cancer-related genes by CpG hypermethylation occurs independently of their spatial organization in the nucleus.Histopathologic grading of anaplasia in retinoblastoma.Protein kinase CK2 in health and disease: CK2: a key player in cancer biologyUsing nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentMechanogenomic control of DNA exposure and sequestration.Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic developmentOrganization of the amplified type I interferon gene cluster and associated chromosome regions in the interphase nucleus of human osteosarcoma cellsTERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphismAn architectural genetic and epigenetic perspective.Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.Valproic Acid Induces Telomerase Reverse Transcriptase Expression during Cortical Development.Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.
P2860
Q24541393-BEE5AAEC-B21D-4FA8-A585-3817CAB651DEQ24792893-BBA74064-FDDB-4D31-8A58-C6FF46625D3FQ30384499-C4904EB2-194D-4EF7-8656-DE01002B0CA5Q30481145-A2071CD3-259E-49A7-9DA6-706778382B00Q33940715-BDD246BA-EBDB-496C-9958-F792CF11887DQ34180715-4DCB22AB-6A7B-45A2-B2D0-444C2EB7EEF8Q34540525-D01513BC-C2F9-4A8C-9EF6-25E39F5F9647Q35181369-27024116-BEAC-4157-A8CB-A0FF7736EF7EQ35270830-8D72E3E0-C2D3-4BFB-8130-8E3618B8B8B4Q35966831-6DEDF111-6C03-4F21-9719-8B70B1C9A62BQ36081363-718C605E-F94E-4C78-842B-67F4974EBBBCQ37109508-F628270C-7F0D-43C8-8A3E-971DB76D68C3Q37208156-2276715D-6376-4589-9875-5BC0C50DA943Q37256055-0BCC8747-26AD-4F28-BB48-B06019FEFAD0Q37823830-DFF666C7-8645-4612-9663-193996079D0DQ42120683-87D33011-7FDA-42BB-A2F9-485046241B5BQ47138840-447B2129-5259-4132-91DE-78022FDE8394Q47295917-66FCFF17-4257-4DF0-8E36-4E0CFC609A4D
P2860
Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nuclear structure-gene express ...... ant gene expression in cancer.
@ast
Nuclear structure-gene express ...... ant gene expression in cancer.
@en
type
label
Nuclear structure-gene express ...... ant gene expression in cancer.
@ast
Nuclear structure-gene express ...... ant gene expression in cancer.
@en
prefLabel
Nuclear structure-gene express ...... ant gene expression in cancer.
@ast
Nuclear structure-gene express ...... ant gene expression in cancer.
@en
P2093
P1433
P1476
Nuclear structure-gene express ...... ant gene expression in cancer.
@en
P2093
P304
P407
P577
2000-04-01T00:00:00Z